ALLY vs SRPT · P/E 65, rev $7.91B vs rev $1.90B
Ally Financial Inc (ALLY) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Ally Financial Inc (ALLY) is a credit services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ALLY revenue for 2025-12-31 was $7.91B. Net income was $852.0M. Revenue was down 3.3% from 2024-12-31 to 2025-12-31. ALLY currently screens at market cap $11.95B and trailing P/E 64.8.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
ALLY currently screens at market cap $11.95B and trailing P/E 64.8. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ALLY and SRPT stock pages for the full models.
Not investment advice.